Terry L. Murdock is VP at G1 Therapeutics, Inc. (GTHX). They have made 11 open-market trades across 1 company since 2018, most recently 2024-09-18.
CIK 0001274071
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GTHX | 145,912 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2024-09-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GTHX | SELL | 2024-07-05 | 2024-07-08 | $2.51 | $6K | +42.2% | +175.8% | N/A |
| GTHX | SELL | 2024-05-13 | 2024-05-15 | $4.79 | $39K | -26.2% | -39.7% | +53.6% |
| GTHX | SELL | 2024-01-03 | 2024-01-08 | $3.09 | $12K | +1.8% | +43.8% | +42.0% |
| GTHX | SELL · 10b5-1 | 2023-07-05 | 2023-07-07 | $2.45 | $3K | +10.8% | -15.8% | -47.3% |
| GTHX | SELL | 2023-01-04 | 2023-01-05 | $5.53 | $13K | +24.8% | +45.1% | -51.4% |
| GTHX | SELL | 2022-07-05 | 2022-07-06 | $5.17 | $3K | +24.5% | +102.6% | +99.4% |
| GTHX | SELL | 2022-01-05 | 2022-01-05 | $10.61 | $15K | -10.7% | -4.2% | -21.3% |
| GTHX | SELL | 2018-12-03 | 2018-12-03 | $38.54 | $272K | -21.7% | -49.8% | -45.0% |
| GTHX | SELL | 2018-11-05 | 2018-11-07 | $41.53 | $292K | -14.2% | -26.6% | -54.1% |
| GTHX | SELL | 2018-10-03 | 2018-10-05 | $49.18 | $346K | +5.1% | -3.5% | -58.4% |
| GTHX | SELL | 2018-09-04 | 2018-09-06 | $59.98 | $422K | +4.0% | -27.5% | -42.3% |
| GTHX | SELL | 2018-08-03 | 2018-08-06 | $50.60 | $356K | +11.1% | +16.4% | -17.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.